Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei Mu

Showing results (531-540 of 542) with videos related to

Pageof 55
Sort By:
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|July 12, 2012
[Comparison of the short-term outcomes of surgical treatment for non-small cell lung cancer via video assisted thoracoscopic surgery and open thoracotomy]Ju-wei Mu, Bai-hua Zhang, Ning Li, et al.
Liver Cancer|June 30, 2025
Transarterial Chemoembolization plus Sorafenib versus Sorafenib Alone in Advanced Hepatocellular Carcinoma (SELECT): A Multicenter, Phase 3, Randomized, Controlled TrialYan Zhao, Wei Bai, Rong Ding, et al.
Zhonghua Yi Xue Za Zhi|December 18, 2010
[Comparison of outcomes after transradial intervention in patients of different age groups]Sheng-wen Liu, Shu-bin Qiao, Bo Xu, et al.
Cancer Biology & Medicine|May 22, 2013
Application of video-assisted thoracic surgery in the standard operation for thoracic tumorsJu-Wei Mu, Gui-Yu Chen, Ke-Lin Sun, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|May 26, 2011
[The in-hospital outcome and predictors of major adverse cardiac events after transradial intervention in patients with coronary artery disease]Sheng-Wen Liu, Shu-Bin Qiao, Bo Xu, et al.
Liver Cancer|July 11, 2020
Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational StudyZhexuan Wang, Enxin Wang, Wei Bai, et al.
World Journal of Gastroenterology|February 28, 2020
Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective studyZhe-Xuan Wang, En-Xin Wang, Wei Bai, et al.
Cell|January 28, 2026
An organ-conformal, kirigami-structured bioelectronic patch for precise intracellular deliveryYuqiong Wang, Lamei Du, Han Wu, et al.
European Radiology|April 6, 2022
Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolizationDongdong Xia, Qiuhe Wang, Wei Bai, et al.
Scientific Data|June 28, 2022
A Global Building Occupant Behavior DatabaseBing Dong, Yapan Liu, Wei Mu, et al.
Pageof 55

Showing results (531-540 of 542) with videos related to

Sort By:
Pageof 55
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|July 12, 2012
[Comparison of the short-term outcomes of surgical treatment for non-small cell lung cancer via video assisted thoracoscopic surgery and open thoracotomy]Ju-wei Mu, Bai-hua Zhang, Ning Li, et al.
Liver Cancer|June 30, 2025
Transarterial Chemoembolization plus Sorafenib versus Sorafenib Alone in Advanced Hepatocellular Carcinoma (SELECT): A Multicenter, Phase 3, Randomized, Controlled TrialYan Zhao, Wei Bai, Rong Ding, et al.
Zhonghua Yi Xue Za Zhi|December 18, 2010
[Comparison of outcomes after transradial intervention in patients of different age groups]Sheng-wen Liu, Shu-bin Qiao, Bo Xu, et al.
Cancer Biology & Medicine|May 22, 2013
Application of video-assisted thoracic surgery in the standard operation for thoracic tumorsJu-Wei Mu, Gui-Yu Chen, Ke-Lin Sun, et al.
Zhonghua Xin Xue Guan Bing Za Zhi|May 26, 2011
[The in-hospital outcome and predictors of major adverse cardiac events after transradial intervention in patients with coronary artery disease]Sheng-Wen Liu, Shu-Bin Qiao, Bo Xu, et al.
Liver Cancer|July 11, 2020
Exploratory Analysis to Identify Candidates Benefitting from Combination Therapy of Transarterial Chemoembolization and Sorafenib for First-Line Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Observational StudyZhexuan Wang, Enxin Wang, Wei Bai, et al.
World Journal of Gastroenterology|February 28, 2020
Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective studyZhe-Xuan Wang, En-Xin Wang, Wei Bai, et al.
Cell|January 28, 2026
An organ-conformal, kirigami-structured bioelectronic patch for precise intracellular deliveryYuqiong Wang, Lamei Du, Han Wu, et al.
European Radiology|April 6, 2022
Optimal time point of response assessment for predicting survival is associated with tumor burden in hepatocellular carcinoma receiving repeated transarterial chemoembolizationDongdong Xia, Qiuhe Wang, Wei Bai, et al.
Scientific Data|June 28, 2022
A Global Building Occupant Behavior DatabaseBing Dong, Yapan Liu, Wei Mu, et al.
Pageof 55